Company intelligence / Profile preview

Biological Advance Research

Ownership: Private
Development stage: Other

Overview

Biological Advance Research is a biotechnology company focused on the research and development of novel therapeutic solutions. The company primarily engages in early-stage discovery and pre-clinical studies aimed at addressing unmet needs in infectious diseases and oncology. By leveraging advanced biological research techniques, the firm seeks to identify and validate new drug targets and therapeutic candidates. Biological Advance Research operates as a private entity, often collaborating with academic and industrial partners to advance its internal pipeline.

Therapeutic areas: Infectious DiseasesOncology
Modalities: Small moleculeBiologic
Industry: Biotech

Beyond the preview

Go deeper on Biological Advance Research.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Biological Advance Research.

Explore the full profile